MA41599A - Formes cristallines d'un composé pyrrolopyridine - Google Patents

Formes cristallines d'un composé pyrrolopyridine

Info

Publication number
MA41599A
MA41599A MA041599A MA41599A MA41599A MA 41599 A MA41599 A MA 41599A MA 041599 A MA041599 A MA 041599A MA 41599 A MA41599 A MA 41599A MA 41599 A MA41599 A MA 41599A
Authority
MA
Morocco
Prior art keywords
crystalline forms
pyrrolopyridine compound
pyrrolopyridine
compound
crystalline
Prior art date
Application number
MA041599A
Other languages
English (en)
Inventor
Christopher M Lindemann
Weidong Liu
Joseph Lubach
Keith L Spencer
Jeffrey Stults
Original Assignee
Array Biopharma Inc
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55521844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41599(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Array Biopharma Inc, Genentech Inc filed Critical Array Biopharma Inc
Publication of MA41599A publication Critical patent/MA41599A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
MA041599A 2015-02-26 2016-02-25 Formes cristallines d'un composé pyrrolopyridine MA41599A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562121396P 2015-02-26 2015-02-26

Publications (1)

Publication Number Publication Date
MA41599A true MA41599A (fr) 2018-01-02

Family

ID=55521844

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041599A MA41599A (fr) 2015-02-26 2016-02-25 Formes cristallines d'un composé pyrrolopyridine

Country Status (21)

Country Link
US (2) US20160251350A1 (fr)
EP (1) EP3262042A1 (fr)
JP (1) JP2018506562A (fr)
KR (1) KR20170118762A (fr)
CN (1) CN107406447A (fr)
AR (1) AR103801A1 (fr)
AU (1) AU2016225070A1 (fr)
BR (1) BR112017018230A2 (fr)
CA (1) CA2976665A1 (fr)
CL (1) CL2017002180A1 (fr)
CO (1) CO2017009662A2 (fr)
CR (1) CR20170439A (fr)
HK (1) HK1246786A1 (fr)
IL (1) IL254115A0 (fr)
MA (1) MA41599A (fr)
MX (1) MX2017010888A (fr)
PE (1) PE20171327A1 (fr)
PH (1) PH12017501532A1 (fr)
RU (1) RU2017133093A (fr)
SG (1) SG11201706824TA (fr)
WO (1) WO2016138458A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021014640A8 (pt) * 2019-01-29 2022-12-20 Huya Bioscience Int Llc Sais de sulcardina
WO2020167845A1 (fr) * 2019-02-12 2020-08-20 Impact Biomedicines, Inc. Formes cristallines d'un inhibiteur de jak2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CL2009001152A1 (es) * 2008-05-13 2009-10-16 Array Biopharma Inc Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
US8481557B2 (en) * 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
US9370567B2 (en) * 2010-11-16 2016-06-21 Array Biopharma Inc. Combination of checkpoint kinase 1 inhibitors and WEE 1 kinase inhibitors
WO2015027090A1 (fr) * 2013-08-22 2015-02-26 Genentech, Inc. Intermédiaires et procédés pour la préparation de composés
RU2672725C2 (ru) * 2013-08-22 2018-11-19 Дженентек, Инк. Способ получения соединения

Also Published As

Publication number Publication date
CA2976665A1 (fr) 2016-09-01
SG11201706824TA (en) 2017-09-28
RU2017133093A3 (fr) 2019-08-23
CN107406447A (zh) 2017-11-28
US20180282324A1 (en) 2018-10-04
HK1246786A1 (zh) 2018-09-14
WO2016138458A1 (fr) 2016-09-01
CR20170439A (es) 2018-01-08
CO2017009662A2 (es) 2018-02-28
CL2017002180A1 (es) 2018-03-16
PH12017501532A1 (en) 2018-02-05
PE20171327A1 (es) 2017-09-12
US20160251350A1 (en) 2016-09-01
AU2016225070A1 (en) 2017-09-07
MX2017010888A (es) 2017-12-15
RU2017133093A (ru) 2019-03-26
AR103801A1 (es) 2017-06-07
BR112017018230A2 (pt) 2018-04-17
KR20170118762A (ko) 2017-10-25
JP2018506562A (ja) 2018-03-08
IL254115A0 (en) 2017-10-31
EP3262042A1 (fr) 2018-01-03

Similar Documents

Publication Publication Date Title
MA47433A (fr) Composé de quinazoline
MA45940A (fr) Composé hétérocyclique
KR20180084996A (ko) 신규 비페닐 화합물 또는 그의 염
DK3372584T5 (da) Fremgangsmåde til fremstillingen af en diarylthiohydantoin-forbindelse
EP3619208C0 (fr) Formes cristallines d'un composé inhibiteur de jak
DK3472157T3 (da) Krystallinske faste former af en bet-inhibitor
EP3341364C0 (fr) Procédé pour la préparation d'un composé à double effet inhibiteur de la néprilysine-récepteur de l'angiotensine
BR112017017193A2 (pt) compostos herbicidas
DK3271435T3 (da) Sammensatte søjlestrukturer
MA42840A (fr) Composé pharmaceutique
MA41203A (fr) Procédés pour la préparation d'un composé diaryl-thiohydantoïne
MA43275A (fr) Composé de pyranodipyridine
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3130592T3 (da) ANALOGER AF 4H-PYRAZOLO[1,5-á]BENZIMIDAZOL-FORBINDELSER SOM PARPINHIBITORER
MA47129A (fr) Sel de composé pipéridine substitué
MA44781A (fr) Composé hétérocyclique condensé
MA46266A (fr) Formes cristallines
MA41599A (fr) Formes cristallines d'un composé pyrrolopyridine
ZA201606653B (en) Solid forms of a pharmaceutically active compound
MA52297A (fr) Composé hétérocyclique
IL278054A (en) The crystalline forms of a compound
IL276195A (en) Salt forms of an organic compound
HK1252841A1 (zh) 噻吩並嘧啶化合物的鹽酸鹽的結晶形式
ZA201607107B (en) Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound
DK3280704T3 (da) Fremgangsmåde til syntese af en prækursor af en enkelt isomer af dairy-lacton